Concepedia

Amy M. Richards

AM

7

Publications

1.2K

Citations

7

H-Index

1985

Active since

Affiliations

Sanofi (United States)(Current)

Amy M. Richards is an author at Sanofi (United States) specializing in spinal cord injury, medicine, and neurology.

Top concepts

Publications per year

1985–2021

7

Publications

7

Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy

Marco A. Passini, Jie Bu, Amy M. Richards et al. · Science Translational Medicine · 2011 · 548 citations · Full text

CNS-targeted gene therapy improves survival and motor function in a mouse model of spinal muscular atrophy

Marco A. Passini, Jie Bu, Eric M. Roskelley et al. · Journal of Clinical Investigation · 2010 · 290 citations · Full text

, , +20

Glucosylceramide synthase inhibition alleviates aberrations in synucleinopathy models

S. Pablo Sardi, Catherine Viel, Jennifer Clarke et al. · Proceedings of the National Academy of Sciences · 2017 · 196 citations · Full text

Translational Fidelity of Intrathecal Delivery of Self-Complementary AAV9–Survival Motor Neuron 1 for Spinal Muscular Atrophy

Marco A. Passini, Jie Bu, Amy M. Richards et al. · Human Gene Therapy · 2014 · 86 citations

, , +13

Preclinical pharmacology of glucosylceramide synthase inhibitor venglustat in a GBA-related synucleinopathy model

Catherine Viel, Jennifer Clarke, Can Kayatekin et al. · Scientific Reports · 2021 · 26 citations · Full text

Rows per page

1–5 of 7